SCOPE 2018

Medrio expanding globally following $30m investment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/KenTannenbaum)
(Image: Getty/KenTannenbaum)
The healthcare technology company Medrio is expanding its business both internationally and domestically following a $30m investment – and demand knocking on its door.

Last year Medrio closed a $30m equity investment from Questa Capital Management, a venture capital firm. The investment was the first of its kind for the company’s twelve-year history, according to Medrio.

We’ve seen a lot of demand both in Europe and Asia​,” Leslie Olsen, vice president of product marketing at Medrio told us at the SCOPE Summit earlier this month.

Speaking at the company’s booth during SCOPE, Olsen said she was hearing a lot of the same things she usually hears at such events. Mainly, “We need tools that will easily integrate with what we’re doing. That don’t require a ton of training​.”

People who are looking to be more nimble – to fail fast, to make a decision quickly … we help them do that​,” she said.

Most recently, the company announced that Linear Clinical Research, an Australia-based Phase I unit, has implemented Medrio’s technology – a move that marked the company's first departure from paper-based data capture.

“[Liner Clinical Research] helped us understand that we have a real footprint there [in Asia]​,” said Olsen.

For us we’re really just trying to capitalize on the demand that’s coming to us, just knocking on our door​,” she added.

To meet this increasing demand, Medrio is opening offices in Charlotte, NC Heidelberg, Germany, and Tokyo, Japan, and is also increasing its business development headcount.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars